Providence, R.I.-based Lifespan is partnering with digital health company Eko to develop artificial intelligence that can help diagnose pulmonary hypertension, the firm said Sept. 20.
Eko is using a $2.7 million small business innovation research grant from the National Institutes of Health to design a machine learning algorithm that would detect the condition using the company's smart stethoscopes. The method will employ data from phonocardiograms and electrocardiograms and is designed to be less invasive and costly than the current standard of EKG and right-heart catheterization.
Read more at Becker's Hospital Review